Literature DB >> 27206512

Microfluidic manufacture of rt-PA -loaded echogenic liposomes.

Madhuvanthi A Kandadai1,2, Prithviraj Mukherjee3, Himanshu Shekhar4, George J Shaw5, Ian Papautsky3, Christy K Holland4.   

Abstract

Echogenic liposomes (ELIP), loaded with recombinant tissue-type plasminogen activator (rt-PA) and microbubbles that act as cavitation nuclei, are under development for ultrasound-mediated thrombolysis. Conventional manufacturing techniques produce a polydisperse rt-PA-loaded ELIP population with only a small percentage of particles containing microbubbles. Further, a polydisperse population of rt-PA-loaded ELIP has a broadband frequency response with complex bubble dynamics when exposed to pulsed ultrasound. In this work, a microfluidic flow-focusing device was used to generate monodisperse rt-PA-loaded ELIP (μtELIP) loaded with a perfluorocarbon gas. The rt-PA associated with the μtELIP was encapsulated within the lipid shell as well as intercalated within the lipid shell. The μtELIP had a mean diameter of 5 μm, a resonance frequency of 2.2 MHz, and were found to be stable for at least 30 min in 0.5 % bovine serum albumin. Additionally, 35 % of μtELIP particles were estimated to contain microbubbles, an order of magnitude higher than that reported previously for batch-produced rt-PA-loaded ELIP. These findings emphasize the advantages offered by microfluidic techniques for improving the encapsulation efficiency of both rt-PA and perflurocarbon microbubbles within echogenic liposomes.

Entities:  

Keywords:  Echogenic liposomes; Microfluidic flow-focusing; Recombinant tissue-type plasminogen activator; Stroke treatment; Ultrasound-mediated thrombolysis

Mesh:

Substances:

Year:  2016        PMID: 27206512      PMCID: PMC4920071          DOI: 10.1007/s10544-016-0072-0

Source DB:  PubMed          Journal:  Biomed Microdevices        ISSN: 1387-2176            Impact factor:   2.838


  53 in total

Review 1.  Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations.

Authors:  J J Escobar-Chávez; M López-Cervantes; A Naïk; Y N Kalia; D Quintanar-Guerrero; A Ganem-Quintanar
Journal:  J Pharm Pharm Sci       Date:  2006       Impact factor: 2.327

2.  Tailoring the size distribution of ultrasound contrast agents: possible method for improving sensitivity in molecular imaging.

Authors:  Esra Talu; Kanaka Hettiarachchi; Shukui Zhao; Robert L Powell; Abraham P Lee; Marjorie L Longo; Paul A Dayton
Journal:  Mol Imaging       Date:  2007 Nov-Dec       Impact factor: 4.488

3.  Enhancement of fibrinolysis with 40-kHz ultrasound.

Authors:  V Suchkova; F N Siddiqi; E L Carstensen; D Dalecki; S Child; C W Francis
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

4.  Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes.

Authors:  Denise A B Smith; Sampada S Vaidya; Jonathan A Kopechek; Shao-Ling Huang; Melvin E Klegerman; David D McPherson; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2010-01       Impact factor: 2.998

5.  Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes.

Authors:  George J Shaw; Jason M Meunier; Shao-Ling Huang; Christopher J Lindsell; David D McPherson; Christy K Holland
Journal:  Thromb Res       Date:  2009-02-13       Impact factor: 3.944

6.  Experimental validation of a finite-difference model for the prediction of transcranial ultrasound fields based on CT images.

Authors:  Guillaume Bouchoux; Kenneth B Bader; Joseph J Korfhagen; Jason L Raymond; Ravishankar Shivashankar; Todd A Abruzzo; Christy K Holland
Journal:  Phys Med Biol       Date:  2012-11-15       Impact factor: 3.609

7.  Controllable microfluidic synthesis of multiphase drug-carrying lipospheres for site-targeted therapy.

Authors:  Kanaka Hettiarachchi; Shirley Zhang; Steven Feingold; Abraham P Lee; Paul A Dayton
Journal:  Biotechnol Prog       Date:  2009 Jul-Aug

8.  CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke.

Authors:  Andrei V Alexandrov; Anne W Wojner; James C Grotta
Journal:  J Neuroimaging       Date:  2004-04       Impact factor: 2.486

9.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

10.  Recombinant protein-stabilized monodisperse microbubbles with tunable size using a valve-based microfluidic device.

Authors:  Francesco E Angilè; Kevin B Vargo; Chandra M Sehgal; Daniel A Hammer; Daeyeon Lee
Journal:  Langmuir       Date:  2014-10-13       Impact factor: 3.882

View more
  8 in total

1.  Loss of gas from echogenic liposomes exposed to pulsed ultrasound.

Authors:  Jason L Raymond; Ying Luan; Tao Peng; Shao-Ling Huang; David D McPherson; Michel Versluis; Nico de Jong; Christy K Holland
Journal:  Phys Med Biol       Date:  2016-11-03       Impact factor: 3.609

2.  Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.

Authors:  Shan Liu; Xiaozhou Feng; Rong Jin; Guohong Li
Journal:  Expert Opin Drug Deliv       Date:  2017-09-28       Impact factor: 6.648

3.  In vitro thrombolytic efficacy of echogenic liposomes loaded with tissue plasminogen activator and octafluoropropane gas.

Authors:  Himanshu Shekhar; Kenneth B Bader; Shenwen Huang; Tao Peng; Shaoling Huang; David D McPherson; Christy K Holland
Journal:  Phys Med Biol       Date:  2016-12-21       Impact factor: 3.609

Review 4.  Thrombolytic Agents: Nanocarriers in Controlled Release.

Authors:  Soodabeh Hassanpour; Han-Jun Kim; Arezoo Saadati; Peyton Tebon; Chengbin Xue; Floor W van den Dolder; Jai Thakor; Behzad Baradaran; Jafar Mosafer; Amir Baghbanzadeh; Natan Roberto de Barros; Mahmoud Hashemzaei; Kang Ju Lee; Junmin Lee; Shiming Zhang; Wujin Sun; Hyun-Jong Cho; Samad Ahadian; Nureddin Ashammakhi; Mehmet R Dokmeci; Ahad Mokhtarzadeh; Ali Khademhosseini
Journal:  Small       Date:  2020-08-12       Impact factor: 13.281

5.  In vitro characterization of sonothrombolysis and echocontrast agents to treat ischemic stroke.

Authors:  Himanshu Shekhar; Robert T Kleven; Tao Peng; Arunkumar Palaniappan; Kunal B Karani; Shaoling Huang; David D McPherson; Christy K Holland
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

Review 6.  Nanomaterials as Ultrasound Theragnostic Tools for Heart Disease Treatment/Diagnosis.

Authors:  Edouard Alphandéry
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

Review 7.  Targeted Delivery of Plasminogen Activators for Thrombolytic Therapy: An Integrative Evaluation.

Authors:  Yunn-Hwa Ma; Chih-Hsin Liu; Yueh Liang; Jyh-Ping Chen; Tony Wu
Journal:  Molecules       Date:  2019-09-19       Impact factor: 4.411

8.  Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.

Authors:  Hongyin Ma; Zhenmin Jiang; Jiayun Xu; Junqiu Liu; Zhen-Ni Guo
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.